ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P86
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025189.34%
2024-46.19%
2023481.24%
2022-1039.28%
2021-78.24%
2020-66.54%
2019-31.97%
201870.16%
201743.49%
201659.13%